Hiroki Ide Selected Research

Hiroki Ide Research Topics

Disease

40	Neoplasms (Cancer) 04/2022 - 01/2006
33	Urinary Bladder Neoplasms (Bladder Cancer) 04/2022 - 03/2007
23	Carcinoma (Carcinomatosis) 09/2021 - 01/2011
8	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2018
7	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 01/2010
7	Carcinogenesis 08/2020 - 01/2015
3	Neoplasm Metastasis (Metastasis) 03/2014 - 01/2011
2	Carcinoma in Situ 02/2021 - 01/2018
2	Hemorrhage 12/2012 - 01/2006
1	Disease Progression 09/2021
1	Deglutition Disorders (Dysphagia) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	RNA Virus Infections 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 05/2015

Drug/Important Bio-Agent (IBA)

19	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 01/2015
11	AndrogensIBA 09/2021 - 01/2012
9	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 03/2013
7	Small Interfering RNA (siRNA)IBA 01/2020 - 08/2013
6	Estrogen ReceptorsIBA 11/2021 - 11/2016
6	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2020 - 10/2015
5	Hormones (Hormone)IBA 08/2020 - 01/2010
4	Dihydrotestosterone (Androstanolone)IBA 01/2020 - 10/2015
4	hydroxyflutamideIBA 01/2020 - 10/2015
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2016
4	EnzymesIBA 01/2018 - 09/2012
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2013
4	Gemcitabine FDA Link 06/2016 - 01/2011
3	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2021 - 01/2017
3	SteroidsIBA 08/2020 - 01/2015
3	CarcinogensIBA 01/2020 - 12/2019
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 12/2018
3	Flutamide (Eulexin)FDA LinkGeneric 01/2020 - 10/2016
3	GlucocorticoidsIBA 12/2019 - 10/2015
3	silodosin FDA Link 01/2018 - 01/2015
3	Messenger RNA (mRNA)IBA 08/2016 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 08/2016 - 01/2015
3	C-Reactive ProteinIBA 08/2015 - 11/2013
3	RNA (Ribonucleic Acid)IBA 05/2015 - 09/2014
3	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 09/2012
2	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2020 - 11/2016
2	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2020 - 10/2015
2	LigandsIBA 01/2020 - 10/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018 - 10/2015
2	enzalutamideIBA 01/2017 - 10/2016
2	bicalutamide (Casodex)FDA LinkGeneric 01/2017 - 10/2016
2	Fibrinogen (Factor I)FDA Link 08/2015 - 05/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2015 - 01/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2015 - 01/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2015 - 01/2015
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2014 - 09/2012
2	Thymidylate SynthaseIBA 08/2013 - 09/2012
2	Docetaxel (Taxotere)FDA Link 01/2012 - 01/2010
1	Therapeutic UsesIBA 04/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	ButylhydroxybutylnitrosamineIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	GW 4869IBA 01/2020
1	NitrosaminesIBA 12/2019
1	MethylcholanthreneIBA 12/2019
1	prednylidene (Pred)IBA 12/2019
1	gamma-Globulins (gamma-Globulin)IBA 01/2019
1	lidofenin (HIDA)IBA 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2018
1	AlbuminsIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Betulinic AcidIBA 01/2018
1	parthenolideIBA 01/2018
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 01/2018
1	GlobulinsIBA 01/2018
1	UridineIBA 01/2018
1	Cyclin EIBA 01/2017
1	AgarIBA 01/2017
1	Cyclin D1IBA 01/2017
1	Androgen Antagonists (Antiandrogens)IBA 10/2016
1	thiazolyl blueIBA 10/2016
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015
1	Methotrexate (Mexate)FDA LinkGeneric 04/2015

Therapy/Procedure

12	Nephroureterectomy 12/2016 - 06/2013
9	Cystectomy 04/2022 - 03/2007
8	Drug Therapy (Chemotherapy) 11/2021 - 01/2011
6	Therapeutics 11/2021 - 03/2013
4	Neoadjuvant Therapy 04/2022 - 01/2015
4	Transurethral Resection of Bladder 10/2021 - 02/2021
4	Castration 12/2018 - 01/2012
3	Adjuvant Chemotherapy 04/2022 - 04/2015
3	Immunotherapy 11/2021 - 09/2014
3	Prostatectomy (Retropubic Prostatectomy) 06/2016 - 04/2010
2	Radiotherapy 11/2021 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 08/2016 - 01/2011
1	Drug Tapering 09/2021
1	Chemoprevention 01/2020
1	Home Nursing (Nursing, Home) 01/2019